MOTS-C 10mg

Description

MOTS-C 10mg, organized for a careful laboratory review

Purity Collective supplies MOTS-C 10mg in a lyophilized vial for qualified laboratory research. This page connects the catalog identity, stated quantity, SKU and available analytical records so procurement teams can evaluate the listing from traceable facts rather than broad outcome claims.

The attached records answer different questions and use different lot identifiers. Review each document in full, including the compound, lot, method, dates, printed specifications and reported results. Measurements from one submitted sample should not be treated as a guarantee for every unit.

Product details

Available analytical documents

Open the MOTS-C 10mg UPLC/MS report and the MOTS-C endotoxin report to review the complete records. Purity Collective’s guide to reading a peptide COA explains how to compare identity, lot, method, date, specification and result fields.

The UPLC/MS report identifies MOTS-c and lot PCCL-8553761. For that submitted sample, it records a measured quantity of 10.35mg against a 10mg specification and a purity result of 99.28% against a greater-than-98% specification. It lists March 15, 2026 as the received date and March 22, 2026 as the analysis date.

The separate endotoxin report identifies lot PCCL-8553761-E and records a result below 0.05 EU/mL. It does not print an endotoxin acceptance specification. It also lists April 3, 2026 as the analysis date and April 8, 2026 as the received date, so the displayed analysis date is five days earlier than the displayed received date. The reports do not establish sterility, safety, suitability or performance.

Keep quantity variants and their evidence separate

The MOTS-C 40mg listing is a distinct catalog record with a different SKU and listed quantity. No product-specific analytical PDF is attached to that page at publication. Do not transfer the 10mg lot identifiers, dates or reported results to the 40mg variant. For identity/status context and quantity-variant review, read the MOTS-C research records and quantity variant guide.

Before you order

• Confirm that MOTS-C, the 10mg listed quantity and SKU PC-MOTS-C-10MG match the procurement request.
• Review both reports in full and keep their separate lot identifiers visible.
• Keep the 10.35mg and 99.28% results tied to the UPLC/MS sample.
• Note the missing printed endotoxin acceptance specification and the displayed date chronology.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

MOTS-C 10mg FAQs

What is included in this MOTS-C 10mg listing?

The listing identifies MOTS-C with a stated quantity of 10mg, supplied in a lyophilized vial under SKU PC-MOTS-C-10MG for qualified laboratory research.

Which analytical documents are available?

The page links directly to a two-page UPLC/MS report and a separate endotoxin report. Each document should be reviewed as a complete record, including its lot, method, dates, specification fields and results.

What does the MOTS-C UPLC/MS report show?

For submitted lot PCCL-8553761, the report records a measured quantity of 10.35mg and a purity result of 99.28%. These are sample-specific measurements, not universal guarantees.

What limitations should be noted in the reports?

The endotoxin report uses lot PCCL-8553761-E, does not print an acceptance specification and displays an analysis date five days before its received date. Those limitations require buyer review.

Is MOTS-C 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.